BLOOD or RED BLOOD CELL PRODUCTS (Administration or reintroduction of any quantity of autologous, allogenic (homologous) or heterologous blood or red blood cell products of any origin into the circulatory system)

Prohibited method: BLOOD or RED BLOOD CELL PRODUCTS – refer to section M1 (Manipulation of blood and blood components) of the WADA 2026 Prohibited List.

The withdrawal of blood or blood components (including by apheresis), unless performed for:
1) analytical purposes including medical tests or Doping Control, or for
2) donation purposes in a collection center accredited by the relevant regulatory authority of the country in which it operates.